Epidemiology and Diagnosis of Peripheral Arterial Disease in Patients With Chronic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 15, Issue 4, 2008, Pages 378-383

  Ix, Joachim H ^a   Criqui, Michael H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Diagnosis; Epidemiology; Kidney disease; Medial arterial calcification; Peripheral arterial disease

Indexed keywords

ANAMNESIS; ANGIOGRAPHY; ARTERY CALCIFICATION; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; TOE BRACHIAL INDEX;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLETHYSMOGRAPHY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 52249102441     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2008.07.007     Document Type: Article

References (48)

1. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
2. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
3. Keith D.S., Nichols G.A., Gullion C.M., et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
4. O'Hare A.M., Glidden D.V., Fox C.S., et al. High prevalence of peripheral arterial disease in persons with renal insufficiency: Results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 109 (2004) 320-323
5. Leskinen Y., Salenius J.P., Lehtimaki T., et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: Requirements for diagnostics. Am J Kidney Dis 40 (2002) 472-479
6. Suominen V., Rantanen T., Venermo M., et al. Prevalence and Risk Factors of PAD among patients with elevated ABI. Eur J Vasc Endovasc Surg 35 (2008) 709-714
7. London G.M., Guerin A.P., Marchais S.J., Metivier F., Pannier B., and Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18 (2003) 1731-1740
8. O'Hare A.M., Vittinghoff E., Hsia J., et al. Renal insufficiency and the risk of lower extremity peripheral arterial disease: Results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 15 (2004) 1046-1051
9. Coresh J., Astor B.C., Greene T., et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
10. Gregg E.W., Sorlie P., Paulose-Ram R., et al. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 27 (2004) 1591-1597
11. Shlipak M.G., Fried L.F., Crump C., et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 62 (2002) 997-1004
12. Wattanakit K., Folsom A.R., Selvin E., et al. Kidney function and risk of peripheral arterial disease: Results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 18 (2007) 629-636
13. Hsia J., Simon J.A., Lin F., et al. Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: The Heart and Estrogen/Progestin Replacement Study. Circulation 102 (2000) 2228-2232
14. Rajagopalan S., Dellegrottaglie S., Furniss A.L., et al. Peripheral arterial disease in patients with end-stage renal disease: Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 114 (2006) 1914-1922
15. Eggers P.W., Gohdes D., and Pugh J. Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 56 (1999) 1524-1533
16. Feringa H.H., Karagiannis S.E., Schouten O., et al. Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vasc Endovasc Surg 34 (2007) 206-213
17. Chertow G.M., Raggi P., Chasan-Taber S., et al. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19 (2004) 1489-1496
18. Kestenbaum B., Sampson J.N., Rudser K.D., et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16 (2005) 520-528
19. Block G.A., Klassen P.S., Lazarus J.M., et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 (2004) 2208-2218
20. Boaz M., Weinstein T., Matas Z., et al. Peripheral vascular disease and serum phosphorus in hemodialysis: A nested case-control study. Clin Nephrol 63 (2005) 98-105
21. O'Hare A.M., Bertenthal D., Shlipak M.G., et al. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 16 (2005) 514-519
22. Pasqualini L., Schillaci G., Pirro M., et al. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease. J Intern Med 262 (2007) 668-677
23. Shadman R., Allison M.A., and Criqui M.H. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients. J Am Coll Cardiol 49 (2007) 2172-2181
24. Feringa H.H., Bax J.J., Hoeks S., et al. A prognostic risk index for long-term mortality in patients with peripheral arterial disease. Arch Intern Med 167 (2007) 2482-2489
25. Monckeberg J. Uber die reine mediaverkalkung der extremitatenarterien und ihr verhalten zur arteriosklerose. Virchows Arch Pathol Anat 171 (1902) 141-167
26. Dao H.H., Essalihi R., Bouvet C., et al. Evolution and modulation of age-related medial elastocalcinosis: Impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 66 (2005) 307-317
27. Young M.J., Adams J.E., Anderson G.F., et al. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 36 (1993) 615-621
28. Micheletti R.G., Fishbein G.A., Currier J.S., et al. Monckeberg sclerosis revisited: A clarification of the histologic definition of Monckeberg sclerosis. Arch Pathol Lab Med 132 (2008) 43-47
29. Allison M.A., Hiatt W.R., Hirsch A.T., et al. A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life. J Am Coll Cardiol 51 (2008) 1292-1298
30. O'Hare A.M., Katz R., Shlipak M.G., et al. Mortality and cardiovascular risk across the ankle-arm index spectrum: Results from the Cardiovascular Health Study. Circulation 113 (2006) 388-393
31. Resnick H.E., Lindsay R.S., McDermott M.M., et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 109 (2004) 733-739
32. Sutton-Tyrrell K., Venkitachalam L., Kanaya A.M., et al. Relationship of ankle blood pressure to cardiovascular events in older adults. Stroke 39 (2008) 863-869
33. Everhart J.E., Pettitt D.J., Knowler W.C., et al. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia 31 (1988) 16-23
34. de Vinuesa S.G., Ortega M., Martinez P., et al. Subclinical peripheral arterial disease in patients with chronic kidney disease: Prevalence and related risk factors. Kidney Int Suppl 93 (2005) S44-S47
35. Quigley F.G., Faris I.B., and Duncan H.J. A comparison of Doppler ankle pressures and skin perfusion pressure in subjects with and without diabetes. Clin Physiol 11 (1991) 21-25
36. McDermott M.M., Greenland P., Liu K., et al. Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA 286 (2001) 1599-1606
37. Wang J.C., Criqui M.H., Denenberg J.O., et al. Exertional leg pain in patients with and without peripheral arterial disease. Circulation 112 (2005) 3501-3508
38. McGee S.R., and Boyko E.J. Physical examination and chronic lower-extremity ischemia: A critical review. Arch Intern Med 158 (1998) 1357-1364
39. Criqui M.H., Fronek A., Klauber M.R., et al. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: Results from noninvasive testing in a defined population. Circulation 71 (1985) 516-522
40. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344 (2001) 1608-1621
41. Lijmer J.G., Hunink M.G., van den Dungen J.J., et al. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 22 (1996) 391-398
42. Bird C.E., Criqui M.H., Fronek A., et al. Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 4 (1999) 15-21
43. Makisalo H., Lepantalo M., Halme L., et al. Peripheral arterial disease as a predictor of outcome after renal transplantation. Transpl Int 11 (1998) S140-143 suppl 1
44. McCullough P.A. Acute kidney injury with iodinated contrast. Crit Care Med 36 (2008) S204-S211
45. McCullough P.A., Adam A., Becker C.R., et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 98 (2006) 27K-36K
46. Marckmann P., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17 (2006) 2359-2362
47. FDA Information for Health Care Professionals: Gadolinium-based Contrast Agents for Magnetic Resonance Imaging; 2007. Available at: http://www.fda.gov/cder/drug/InfoSheets/HCP/gcca_200705.htm. Accessed August 20, 2008.
48. Kurtkoti J., Snow T., and Hiremagalur B. Gadolinium and nephrogenic systemic fibrosis: association or causation. Nephrology (Carlton) 13 (2008) 235-241